Target Price | $341.27 |
Price | $304.63 |
Potential |
12.03%
register free of charge
|
Number of Estimates | 22 |
22 Analysts have issued a price target Insulet Corporation 2026 .
The average Insulet Corporation target price is $341.27.
This is
12.03%
register free of charge
$380.00
24.74%
register free of charge
$266.00
12.68%
register free of charge
|
|
A rating was issued by 27 analysts: 22 Analysts recommend Insulet Corporation to buy, 5 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Insulet Corporation stock has an average upside potential 2026 of
12.03%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 2.07 | 2.53 |
22.07% | 22.21% | |
EBITDA Margin | 18.81% | 22.73% |
9.03% | 20.83% | |
Net Margin | 20.19% | 10.83% |
66.11% | 46.37% |
21 Analysts have issued a sales forecast Insulet Corporation 2025 . The average Insulet Corporation sales estimate is
This results in the following potential growth metrics:
13 Analysts have issued an Insulet Corporation EBITDA forecast 2025. The average Insulet Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
15 Insulet Corporation Analysts have issued a net profit forecast 2025. The average Insulet Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 5.66 | 3.90 |
102.14% | 31.10% | |
P/E | 78.14 | |
EV/Sales | 8.68 |
15 Analysts have issued a Insulet Corporation forecast for earnings per share. The average Insulet Corporation EPS is
This results in the following potential growth metrics and future valuations:
Insulet Corporation...
Analyst | Rating | Action | Date |
---|---|---|---|
Goldman Sachs |
Locked
➜
Locked
|
Locked | May 30 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | May 27 2025 |
Citigroup |
Locked
➜
Locked
|
Locked | May 22 2025 |
Wolfe Research |
Locked
➜
Locked
|
Locked | May 13 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | May 09 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Apr 30 2025 |
Wolfe Research |
Locked
➜
Locked
|
Locked | Apr 29 2025 |
Analyst Rating | Date |
---|---|
Locked
Goldman Sachs:
Locked
➜
Locked
|
May 30 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
May 27 2025 |
Locked
Citigroup:
Locked
➜
Locked
|
May 22 2025 |
Locked
Wolfe Research:
Locked
➜
Locked
|
May 13 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
May 09 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Apr 30 2025 |
Locked
Wolfe Research:
Locked
➜
Locked
|
Apr 29 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.